Last $39.14 USD
Change Today +0.74 / 1.93%
Volume 183.4K
ACOR On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GS
As of 5:10 PM 12/24/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Martin Grumet Ph.D.

Member of Scientific Advisory Board, Acorda Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 20 board members in 1 different organizations across 1 different industries.

See Board Relationships
----

Background*

Martin Grumet Ph.D. is a Member of the Scientific Advisory Board of Acorda Therapeutics Inc. Dr. Grumet is the Professor of Cell Biology and Neuroscience in the Division of Life Sciences at Rutgers University and he is Director of the W.M. Keck Center for Neuroscience. He is the discoverer of the Ng-CAM protein, a chick homologue of L1. He is a leading researcher of cell adhesion molecules in the nervous system and their roles in central nervous system development and ...

Read Full Background

Corporate Headquarters*

420 Saw Mill River Road
Ardsley, New York 10502

United States

Phone: 914-347-4300
Fax: 914-347-4560

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

PhD
Johns Hopkins University
BS
New York University
BS
Cooper Union for the Advancement of Science and Art, The

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ACOR:US $39.14 USD +0.74

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
James E. Brown D.V.M.Co-Founder, Chief Executive Officer, President and Director
DURECT Corporation
$450.7K
Stanley T. Crooke M.D., Ph.D.Founder, Executive Chairman, Chief Executive Officer, President, Chairman of Science/Medical Committee and Member of Agenda Committee
Isis Pharmaceuticals, Inc.
$1.5M
Keith A. Katkin Chief Executive Officer, President, Director, Member of Executive Committee and Member of Pricing Committee
Avanir Pharmaceuticals, Inc.
$611.8K
James A. Schoeneck Chief Executive Officer, President and Director
DepoMed Inc.
$590.6K
Uli Hacksell Ph.D.Chief Executive Officer, President and Director
ACADIA Pharmaceuticals Inc.
$935.0K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ACORDA THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.